Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 156   

Articles published

MRK 49.16 +0.33 (0.68%)
price chart
Merck & Co. Inc (MRK) Closes 1.25% Up on the Day for February 09
Dow Jones component Merck & Co. Inc (MRK) saw its stock move 1.25% to $49.44, representing a per-share move of $0.61, on volume of 7.82 million shares for Tuesday.
Merck & Co., Inc. Expected to Earn FY2016 Earnings of $3.69 Per Share (MRK)
Merck & Co. logo Merck & Co., Inc. (NYSE:MRK) - Stock analysts at Leerink Swann boosted their FY2016 earnings per share (EPS) estimates for shares of Merck & Co.
Camarda Financial Advisors LLC Has $1144000 Position in Merck & Co., Inc ...  Intercooler Financial
Merck & Co., Inc. (MRK) PT Lowered to $56.00  Daily Political
Will 2016 Be Merck & Co. Inc.'s Best Year Yet?
Things haven't exactly gotten off on the right foot in 2016 either, with domestic and global concerns weighing further on Merck's stock. Then again, Merck remains healthfully profitable and has tools at its disposal to move the needle. This begs the ...
Give Merck Some Credit For Zepatier
Its potential impact on Merck's top and bottom line has been gravely misunderstood and underestimated. The ingenious of Merck not only in the drug but also in its pricing, timing and marketing. These will have yield lucrative opportunities for Merck ...
What analysts have to say about Merck & Co., Inc.?
The shares of Merck & Co., Inc. (NYSE:MRK) currently has mean rating of 2.48 while 3 analysts have recommended the shares as “BUY”, 5 recommended as “OUTPERFORM” and 13 recommended as “HOLD”.
Trending Tickers: Merck & Co. Inc. (NYSE:MRK), Great Southern Bancorp Inc ...
On 4 February, Merck & Co. Inc. (NYSE:MRK) announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for single-dose EMEND� (fosaprepitant dimeglumine) for injection, Merck's substance ...
Tickers Trending: Enova International (NYSE:ENVA), MBT Financial Corp ...  Property Mentor
Merck & Co., Inc: Emend Gets FDA Approval
Merck & Co., (NYSE:MRK) has announced that EMEND� (fosaprepitant dimeglumine) in injection formulation has been approved by the U.S.
Merck & Co., Inc. (NYSE:MRK) Gains Approval Of EMEND Injection From The FDA  Journal Transcript
Most Active Healthcare Stocks- Merck & Co. (NYSE:MRK), AstraZeneca (NYSE ...  Seneca Globe
Merck & Co. Inc (MRK) Closes 1.29% Up on the Day for February 05
Dow Jones component Merck & Co. Inc (MRK) saw its stock move 1.29% to $49.22, representing a per-share move of $0.628, on volume of 12.13 million shares for Friday.
Merck & Co., Inc. Falters After Q4 Report
Merck & Co., Inc. (NYSE: MRK) shares are trading lower by $1.65 at $48.76 in Wednesday's session. Despite a Q4 EPS beat of $0.02 with slightly lower revenues, the Street is focusing on its lower FY 2016 outlook for EPS and revenues.
Featured Stock: Merck & Co., Inc.  CWRU Observer
Merck & Co. Inc (MRK) Closes 1.62% Down on the Day for February 08
Dow Jones component Merck & Co. Inc (MRK) saw its stock move -1.62% to $48.58, representing a per-share move of $0.8, on volume of 9.65 million shares for Monday.